• Neurogene set inducement grants for five new hires, issuing non-qualified stock options covering 8,340 common shares.
• Options were dated Oct. 5, 2026, with an exercise price set at the stock’s closing price that day.
• Award schedule runs four years: 25% vests after one year, then 1/48 vests monthly over three years, contingent on employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610051601BIZWIRE_USPR_____20261005_BW454652) on October 05, 2026, and is solely responsible for the information contained therein.